181 related articles for article (PubMed ID: 7774651)
1. A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells.
Autiero M; Cammarota G; Friedlein A; Zulauf M; Chiappetta G; Dragone V; Guardiola J
Eur J Immunol; 1995 May; 25(5):1461-4. PubMed ID: 7774651
[TBL] [Abstract][Full Text] [Related]
2. Structural study of GCDFP-15/gp17 in disease versus physiological conditions using a proteomic approach.
Caputo E; Camarca A; Moharram R; Tornatore P; Thatcher B; Guardiola J; Martin BM
Biochemistry; 2003 May; 42(20):6169-78. PubMed ID: 12755619
[TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of CD4/TCR-mediated T cell apoptosis by a CD4-binding glycoprotein secreted from breast tumor and seminal vesicle cells.
Gaubin M; Autiero M; Basmaciogullari S; Métivier D; Mis hal Z; Culerrier R; Oudin A; Guardiola J; Piatier-Tonneau D
J Immunol; 1999 Mar; 162(5):2631-8. PubMed ID: 10072505
[TBL] [Abstract][Full Text] [Related]
4. Differential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counterparts from exocrine epithelia.
Caputo E; Autiero M; Mani JC; Basmaciogullari S; Piatier-Tonneau D; Guardiola J
Int J Cancer; 1998 Sep; 78(1):76-85. PubMed ID: 9724097
[TBL] [Abstract][Full Text] [Related]
5. Isolation from a human seminal vesicle library of the cDNA for gp17, a CD4 binding factor.
Autiero M; Bouchier C; Basmaciogullari S; Zaborski P; el Marhomy S; Martin M; Guardiola J; Piatier-Tonneau D
Immunogenetics; 1997; 46(4):345-8. PubMed ID: 9218538
[No Abstract] [Full Text] [Related]
6. Biosynthesis and immunobiochemical characterization of gp17/GCDFP-15. A glycoprotein from seminal vesicles and from breast tumors, in HeLa cells and in Pichia pastoris yeast.
Caputo E; Carratore V; Ciullo M; Tiberio C; Mani JC; Piatier-Tonneau D; Guardiola J
Eur J Biochem; 1999 Oct; 265(2):664-70. PubMed ID: 10504398
[TBL] [Abstract][Full Text] [Related]
7. Surface plasmon resonance analysis of gp17, a natural CD4 ligand from human seminal plasma inhibiting human immunodeficiency virus type-1 gp120-mediated syncytium formation.
Autiero M; Gaubin M; Mani JC; Castejon C; Martin M; el Marhomy S; Guardiola J; Piatier-Tonneau D
Eur J Biochem; 1997 Apr; 245(1):208-13. PubMed ID: 9128743
[TBL] [Abstract][Full Text] [Related]
8. Mapping the CD4 binding domain of gp17, a glycoprotein secreted from seminal vesicles and breast carcinomas.
Basmaciogullari S; Autiero M; Culerrier R; Mani JC; Gaubin M; Mishal Z; Guardiola J; Granier C; Piatier-Tonneau D
Biochemistry; 2000 May; 39(18):5332-40. PubMed ID: 10820003
[TBL] [Abstract][Full Text] [Related]
9. Identification and androgen regulation of two proteins released by T47D human breast cancer cells.
Chalbos D; Haagensen D; Parish T; Rochefort H
Cancer Res; 1987 Jun; 47(11):2787-92. PubMed ID: 3567903
[TBL] [Abstract][Full Text] [Related]
10. A novel aspartyl proteinase from apocrine epithelia and breast tumors.
Caputo E; Manco G; Mandrich L; Guardiola J
J Biol Chem; 2000 Mar; 275(11):7935-41. PubMed ID: 10713110
[TBL] [Abstract][Full Text] [Related]
11. CD4-mediated anchoring of the seminal antigen gp17 onto the spermatozoon surface.
Bergamo P; Balestrieri M; Cammarota G; Guardiola J; Abrescia P
Hum Immunol; 1997 Nov; 58(1):30-41. PubMed ID: 9438207
[TBL] [Abstract][Full Text] [Related]
12. Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions.
Pasquinelli R; Barba P; Capasso I; D'Aiuto M; D'Aiuto G; Anzisi AM; De Berardinis P; Guardiola J
Int J Cancer; 1999 Dec; 84(6):568-72. PubMed ID: 10567900
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein/GCDFP-15 gene.
Myal Y; Iwasiow B; Yarmill A; Harrison E; Paterson JA; Shiu RP
Endocrinology; 1994 Oct; 135(4):1605-10. PubMed ID: 7925123
[TBL] [Abstract][Full Text] [Related]
14. Signet ring variant of lobular carcinoma of the breast: a clinicopathologic and immunohistochemical study.
Raju U; Ma CK; Shaw A
Mod Pathol; 1993 Sep; 6(5):516-20. PubMed ID: 8248106
[TBL] [Abstract][Full Text] [Related]
15. Identification of MAL2, a novel member of the mal proteolipid family, though interactions with TPD52-like proteins in the yeast two-hybrid system.
Wilson SH; Bailey AM; Nourse CR; Mattei MG; Byrne JA
Genomics; 2001 Aug; 76(1-3):81-8. PubMed ID: 11549320
[TBL] [Abstract][Full Text] [Related]
16. The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis.
Clark JW; Snell L; Shiu RP; Orr FW; Maitre N; Vary CP; Cole DJ; Watson PH
Br J Cancer; 1999 Nov; 81(6):1002-8. PubMed ID: 10576657
[TBL] [Abstract][Full Text] [Related]
17. Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma.
Ozaki Y; Kontani K; Hanaoka J; Chano T; Teramoto K; Tezuka N; Sawai S; Fujino S; Yoshiki T; Okabe H; Ohkubo I
Cancer; 2002 Nov; 95(9):1954-62. PubMed ID: 12404290
[TBL] [Abstract][Full Text] [Related]
18. Expression of apocrine differentiation markers in neuroendocrine breast carcinomas of aged women.
Sapino A; Righi L; Cassoni P; Papotti M; Gugliotta P; Bussolati G
Mod Pathol; 2001 Aug; 14(8):768-76. PubMed ID: 11504836
[TBL] [Abstract][Full Text] [Related]
19. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein.
Coney LR; Tomassetti A; Carayannopoulos L; Frasca V; Kamen BA; Colnaghi MI; Zurawski VR
Cancer Res; 1991 Nov; 51(22):6125-32. PubMed ID: 1840502
[TBL] [Abstract][Full Text] [Related]
20. Subtractive immunization using highly metastatic human tumor cells identifies SIMA135/CDCP1, a 135 kDa cell surface phosphorylated glycoprotein antigen.
Hooper JD; Zijlstra A; Aimes RT; Liang H; Claassen GF; Tarin D; Testa JE; Quigley JP
Oncogene; 2003 Mar; 22(12):1783-94. PubMed ID: 12660814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
